Fred E Cohen is Director of Progyny, Inc.. Currently has a direct ownership of 22,693 shares of PGNY, which is worth approximately $317,248. The most recent transaction as insider was on May 23, 2024, when has been sold 6,176 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.7K
0% 3M change
37.39% 12M change
Total Value Held $317,248

Fred E Cohen Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2024
BUY
Grant, award, or other acquisition
-
6,176 Added 21.39%
22,693 Common Stock
May 24 2023
BUY
Grant, award, or other acquisition
-
4,385 Added 20.98%
16,517 Common Stock
Oct 24 2022
BUY
Grant, award, or other acquisition
-
3,480 Added 22.29%
12,132 Common Stock
Oct 24 2021
BUY
Grant, award, or other acquisition
-
2,652 Added 23.46%
8,652 Common Stock
Oct 24 2020
BUY
Grant, award, or other acquisition
-
6,000 Added 50.0%
6,000 Common Stock

Also insider at

VCYT
VERACYTE, INC. Healthcare
CDNA
CareDx, Inc. Healthcare
NTLA
Intellia Therapeutics, Inc. Healthcare
KYTX
Kyverna Therapeutics, Inc.
URGN
UroGen Pharma Ltd. Healthcare
FEC

Fred E Cohen

Director
Cambridge, MA

Track Institutional and Insider Activities on PGNY

Follow Progyny, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PGNY shares.

Notify only if

Insider Trading

Get notified when an Progyny, Inc. insider buys or sells PGNY shares.

Notify only if

News

Receive news related to Progyny, Inc.

Track Activities on PGNY